These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 18753002)
41. Symptom burden in persons with myotonic and facioscapulohumeral muscular dystrophy. Smith AE; McMullen K; Jensen MP; Carter GT; Molton IR Am J Phys Med Rehabil; 2014 May; 93(5):387-95. PubMed ID: 24247759 [TBL] [Abstract][Full Text] [Related]
42. Unilateral abdominal protrusion as the main diagnostic sign of facioscapulohumeral dystrophy. Silva AMSD; Cavalcante WCP; Camelo CG; Mendonça RH; Fortini I; Carvalho MS; Zanoteli E Arq Neuropsiquiatr; 2019 Feb; 77(2):139. PubMed ID: 30810600 [No Abstract] [Full Text] [Related]
43. [Facioscapulohumeral muscular dystrophy - twelve cases from two pedigrees]. An R; Xu Y Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2014 Jun; 31(3):402-3. PubMed ID: 24928028 [No Abstract] [Full Text] [Related]
53. The relationship between regional body composition and quantitative strength in facioscapulohumeral muscular dystrophy (FSHD). Skalsky AJ; Abresch RT; Han JJ; Shin CS; McDonald CM Neuromuscul Disord; 2008 Nov; 18(11):873-80. PubMed ID: 18818077 [TBL] [Abstract][Full Text] [Related]
54. Primary alveolar hypoventilation syndrome complicated with antiphospholipid syndrome. Hara J; Fujimura M; Myou S; Oribe Y; Furusho S; Yamazaki M; Nakao S Intern Med; 2005 Sep; 44(9):987-9. PubMed ID: 16258218 [TBL] [Abstract][Full Text] [Related]
55. Teaching NeuroImages: Coats disease revealing facioscapulohumeral muscular dystrophy. Sgobbi de Souza PV; Vieira de Rezende Pinto WB; de Rezende Batistella GN; Dias RB; Bulle Oliveira AS Neurology; 2016 Jul; 87(4):e39. PubMed ID: 27462044 [No Abstract] [Full Text] [Related]
56. Best practice guidelines on genetic diagnostics of Facioscapulohumeral muscular dystrophy: workshop 9th June 2010, LUMC, Leiden, The Netherlands. Lemmers RJ; O'Shea S; Padberg GW; Lunt PW; van der Maarel SM Neuromuscul Disord; 2012 May; 22(5):463-70. PubMed ID: 22177830 [No Abstract] [Full Text] [Related]
57. Pilot trial of diltiazem in facioscapulohumeral muscular dystrophy. Elsheikh BH; Bollman E; Peruggia M; King W; Galloway G; Kissel JT Neurology; 2007 Apr; 68(17):1428-9. PubMed ID: 17452589 [No Abstract] [Full Text] [Related]
59. Response to: Respiratory muscle dysfunction in facioscapulohumeral muscular dystrophy. Letter to the editor-reference article: sleep-related breathing disorders in facioscapulohumeral dystrophy (https://doi.org/10.1007/s11325-019-01843-1) by Santos DB et al. Runte M; Spiesshoefer J; Heidbreder A; Dreher M; Young P; Brix T; Boentert M Sleep Breath; 2020 Jun; 24(2):675-676. PubMed ID: 31853834 [No Abstract] [Full Text] [Related]
60. A Great Athlete with Muscular Weakness. Bourguiba R; Masingue M; Marc PJ; Lenglet T; Bachmeyer C Am J Med; 2021 Feb; 134(2):e109-e110. PubMed ID: 32835688 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]